MedTrace Logo

Prognotic Role of CMR in Takotsubo Syndrome

NCT06277297 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2025-06-08

No results posted yet for this study

Summary

The primary objective of this observational registry is to develop a comprehensive clinical and imaging score (incorporating echocardiography and cardiac magnetic resonance data) that enhances risk stratification for patients with Takotsubo syndrome.

The secondary objectives of this registry are as follows:

Investigate the diagnostic value of cardiac magnetic resonance parameters in predicting in-hospital and long-term outcomes in patients with Takotsubo syndrome.

Compare the proposed risk stratification score for patients with Takotsubo syndrome with previously existing scores.

Investigate the contribution of machine learning models in predicting in-hospital and long-term outcomes compared to standard clinical scores.

The design and rationale of this registry are available at 10.1097/RTI.0000000000000709

Conditions

  • Takotsubo Cardiomyopathy
  • Machine Learning
  • Magnetic Resonance Imaging

Sponsors & Collaborators

  • Centro Cardiologico Monzino

    collaborator OTHER

  • IRCCS San Raffaele

    collaborator OTHER

  • University of Roma La Sapienza

    collaborator OTHER

  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

    collaborator OTHER_GOV

  • University of Messina

    collaborator OTHER

  • University of Udine

    collaborator OTHER

  • Vannini Hospital Rome

    collaborator UNKNOWN

  • A.O.U. Città della Salute e della Scienza - Molinette Hospital

    collaborator OTHER

  • University Hospital, Bonn

    collaborator OTHER

  • University Hospital, Rouen

    collaborator OTHER

  • University of Cagliari

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-09
Primary Completion
2026-11-30
Completion
2032-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277297 on ClinicalTrials.gov